Trials / Sponsors / GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) Pulmonary Arterial Hypertension | Phase 2 | 2021-04-05 |
| Completed | GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) Pulmonary Artery Hypertension | Phase 2 | 2020-11-12 |
| Completed | Clinical Study of Inhaled GB002 for Treatment of WHO Group I Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension | Phase 1 | 2020-02-04 |
| Completed | Phase 1A Safety Trial of Inhaled PK10571 (GB002) Safety Issues | Phase 1 | 2017-09-06 |